RxSight, Inc. (RXST) DCF Valuation

RxSight, Inc. (RXST) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

RxSight, Inc. (RXST) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore RxSight, Inc.'s (RXST) financial prospects with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to determine RxSight, Inc.'s (RXST) intrinsic value and refine your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 2.2 14.7 22.6 49.0 89.1 163.8 301.3 554.2 1,019.3 1,874.8
Revenue Growth, % 0 554.98 53.92 116.9 81.77 83.92 83.92 83.92 83.92 83.92
EBITDA 130.2 32.2 -41.0 -57.8 -41.0 -15.1 -27.8 -51.1 -93.9 -172.7
EBITDA, % 5809.91 219.06 -181.52 -117.9 -46.07 -9.21 -9.21 -9.21 -9.21 -9.21
Depreciation 3.9 4.0 4.0 4.0 4.2 51.8 95.2 175.1 322.0 592.3
Depreciation, % 175.37 27.33 17.65 8.21 4.76 31.59 31.59 31.59 31.59 31.59
EBIT 126.3 28.1 -45.0 -61.8 -45.3 -16.7 -30.6 -56.3 -103.6 -190.6
EBIT, % 5634.54 191.73 -199.17 -126.11 -50.83 -10.17 -10.17 -10.17 -10.17 -10.17
Total Cash 80.7 69.0 159.3 105.8 127.2 163.8 301.3 554.2 1,019.3 1,874.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .8 2.9 4.9 11.0 20.3
Account Receivables, % 35.21 19.52 21.52 22.36 22.77
Inventories 7.2 8.3 8.0 14.8 17.4 79.2 145.8 268.1 493.0 906.8
Inventories, % 322.13 56.47 35.55 30.27 19.56 48.37 48.37 48.37 48.37 48.37
Accounts Payable 2.2 1.1 1.7 2.6 3.9 40.3 74.1 136.3 250.7 461.1
Accounts Payable, % 98.13 7.73 7.48 5.3 4.34 24.59 24.59 24.59 24.59 24.59
Capital Expenditure -4.1 -2.5 -1.9 -2.4 -4.8 -44.6 -82.1 -150.9 -277.6 -510.6
Capital Expenditure, % -182.33 -17.3 -8.59 -4.88 -5.4 -27.23 -27.23 -27.23 -27.23 -27.23
Tax Rate, % -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243 -0.04116243
EBITAT 126.2 28.1 -45.0 -61.8 -45.3 -16.6 -30.6 -56.3 -103.6 -190.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 120.3 25.3 -44.1 -72.2 -56.5 -54.4 -83.6 -153.7 -282.7 -519.9
WACC, % 10.33 10.33 10.33 10.33 10.33 10.33 10.33 10.33 10.33 10.33
PV UFCF
SUM PV UFCF -741.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -530
Terminal Value -6,370
Present Terminal Value -3,897
Enterprise Value -4,638
Net Debt -7
Equity Value -4,632
Diluted Shares Outstanding, MM 34
Equity Value Per Share -134.42

What You Will Receive

  • Pre-Filled Financial Model: RxSight, Inc.’s actual data provides accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • 🔍 Real-Life RXST Financials: Pre-filled historical and projected data for RxSight, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate RxSight’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize RxSight’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review RxSight, Inc.'s pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose RxSight, Inc. (RXST)?

  • Innovative Solutions: Cutting-edge technology designed to enhance vision correction.
  • Proven Effectiveness: Clinical studies demonstrate significant improvements in patient outcomes.
  • Customizable Options: Tailor treatment plans to meet individual patient needs.
  • User-Friendly Interface: Intuitive design ensures ease of use for both patients and practitioners.
  • Endorsed by Professionals: Trusted by eye care specialists for its reliability and performance.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions regarding investments in RxSight, Inc. (RXST).
  • Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for RxSight, Inc. (RXST).
  • Consultants: Provide clients with expert valuation insights on RxSight, Inc. (RXST) efficiently and accurately.
  • Business Owners: Learn about the valuation of innovative companies like RxSight, Inc. (RXST) to inform your business strategy.
  • Finance Students: Explore valuation methodologies using real-world data from RxSight, Inc. (RXST) and similar firms.

What the Template Contains

  • Pre-Filled DCF Model: RxSight, Inc.’s (RXST) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate RxSight, Inc.’s (RXST) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.